Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01426620 · ClinicalTrials.gov registry record · Phase 2
Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer
A Phase 2 study, sponsored by University of Louisville.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT01426620: Clinical Trial Phase 2 study, sponsored by University of Louisville.
NCT01426620 is a Phase 2 study that was terminated before completion, run by University of Louisville. The registered enrollment target is 4 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01426620, a Phase 2 study, was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
This phase II trial will evaluate phyto-therapy's, in the form of blueberry powder, synergistic effect on second-line therapy for non-small cell lung cancer (NSCLC). The proposition is that the addition of blueberry polyphenolics to routine docetaxel therapy will have a significant, positive effect in the response rate and overall survival.
Primary Outcome
Completion of treatment plan by 10 patients. Feasibility and toxicity for the study will be evaluated in Part 1 of the study based on 10 patients completing the treatment plan (20 if 2 of the initial 10 patients develop toxicities).
Interventions
- DIETARY_SUPPLEMENT Blueberry powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Why NCT01426620 stopped before completion
NCT01426620 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Blueberry powder is the first listed.
NCT01426620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01426620 about?
NCT01426620 is a clinical study titled "Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer". This phase II trial will evaluate phyto-therapy's, in the form of blueberry powder, synergistic effect on second-line therapy for non-small cell lung cancer (NSCLC). The proposition is that the addition of blueberry polyphenolics to routine docetaxel therapy will have a significant, positive effect ...
What is the current status of trial NCT01426620?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2011-06. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01426620?
The interventions under investigation include: Blueberry powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01426620?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01426620's enrollment target sits among peer trials
4 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia